SLC4A1AP: A Potential Drug Target Or Biomarker (G22950)

Target Name: SLC4A1AP

NCBI ID: G22950

SLC4A1AP

SLC4A1AP: A Potential Drug Target Or Biomarker

SLC4A1AP (HLC-3) is a protein that is expressed in various tissues throughout the body. It is a member of the SLC4A family, which is known for its role in the transport of various molecules across cell membranes. One of the functions of this protein is to transport the drug tesmidorin, which is used to treat certain types of cancer.

Recent studies have suggested that SLC4A1AP may also have some potential as a drug target or biomarker. One potential mechanism by which SLC4A1AP could be used as a drug target is its role in cell signaling. SLC4A1AP has been shown to play a role in the regulation of cell signaling pathways, particularly those that are involved in cell growth and differentiation. This suggests that drugs that can inhibit SLC4A1AP activity may be effective in treating certain types of cancer.

Another potential mechanism by which SLC4A1AP could be used as a drug target is its role in the regulation of pain signaling. SLC4A1AP has been shown to play a role in the regulation of pain signaling pathways, which suggests that drugs that can inhibit SLC4A1AP activity may be effective in treating chronic pain.

In addition to its potential as a drug target, SLC4A1AP has also been shown to have potential as a biomarker. This is because it is a protein that is expressed in various tissues throughout the body, which makes it a potential marker for certain types of cancer. Researchers have used techniques such as mass spectrometry and gene expression analysis to identify differentially expressed genes in tissues from mice that were treated with tesmidorin, which suggests that SLC4A1AP may be a useful biomarker for tracking the effectiveness of certain types of cancer treatments.

Overall, SLC4A1AP is a protein that has the potential to be a drug target or biomarker. Further research is needed to fully understand its role in cell signaling and pain regulation, and to determine its potential as a drug.

Protein Name: Solute Carrier Family 4 Member 1 Adaptor Protein

The "SLC4A1AP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC4A1AP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets